Replies to post #347641 on Innovation Pharmaceuticals Inc (IPIX)

[Here Today]

I believe and this is just my take on the situation - because the trial started towards the end of the month in December 2020 and in Russia as per the link Maxinvest was so kind to share, that the developments of the trial from the Russia testing sites are a crucial piece of disclosure for the 10Q and needs to be properly written. If Leo was due to receive Top Line results from the Russia clinical trial’s primary endpoint (time to sustained recovery through Day 29) and the first patient was dosed by 12/17/2020 and the last patient was dosed by 1/07/2021 via all the multiple testing sites in Russia, then Leo did the correct thing in delaying the filing since it is crucial for the report. Just my reading of the tea leaves.

[attilathehunt]

And don't forget developments is plural....there are 2 developments!!

[hockeypond]

I'm hoping, but never have luck waiting for good news on a bio to many variables....